Skip to main content
PKTX logo

PKTX · ProtoKinetix, Inc.

Track PKTX — free
$0.00 At close · Sep 1
Market Cap
$78,316
Shares
391.58M

PKTX metrics

42 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.00
Market cap
$78,316

Price action

19 metrics
Price change (1W)
+0.0%
Price change (30D)
-97.1%
Price change (3M)
-96.2%
Price change (6M)
-97.0%
Price change (YTD)
-96.7%
Price change (1Y)
-97.2%
Trailing year
Price change (5Y)
-99.8%
52-week high
$0.01
52-week low
$0.00
Change from 52-week high
-98.0%
Change from 52-week low
+100.0%
Annualized volatility
8,909.8%
Beta
179.4
RSI (14D)
39.0
Price vs SMA 50
-96.1%
Price vs SMA 200
-96.9%
Avg volume (3M)
119,148
Relative volume
0.1
Average dollar volume
$523

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
391.58M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
P / book
0.3
reciprocal yield 319.8%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-480.3%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings

Profitability

9 metrics
Gross margin
Operating margin
Trailing 12 months
Net margin
Gross profit (TTM)
Operating profit (TTM)
Net income (TTM)
−$376,176
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
Year over year
Net income growth YoY
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
Shares change YoY
+6.7%
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-150.2%
Return on assets
-78.8%
Debt / equity
Current ratio
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
0.1
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$607
Total assets
$477,623
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$181,177
Capital expenditures (TTM)
R&D (TTM)
$103,393
SG&A (TTM)
Stock compensation (TTM)
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%

Short interest

3 metrics
Short interest
Latest settlement
Days to cover
Short-squeeze score

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 1128189 CUSIP 743722100 13F (30d) 1 filings 1 filers Visit website